Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 104 | 176 | 314 | 429 | 463 |
| Cost of Goods | 54 | 131 | 431 | 181 | 191 |
| Gross Profit | 50 | 45 | -117 | 248 | 272 |
| Operating Expenses | 4,736 | 9,443 | 16,493 | 6,942 | 8,757 |
| Operating Income | -4,632 | -9,267 | -16,179 | -6,513 | -8,294 |
| Interest Expense | 8 | 15 | 13 | 14 | 14 |
| Other Income | 110 | 153 | 200 | 38 | -25 |
| Pre-tax Income | -4,530 | -9,129 | -15,992 | -6,489 | -8,333 |
| Net Income Continuous | -4,530 | -9,129 | -15,992 | -6,489 | -8,333 |
| Net Income | $-4,530 | $-9,129 | $-15,992 | $-6,489 | $-8,333 |
| EPS Basic Total Ops | -0.36 | -1.13 | -2.27 | -0.81 | -1.07 |
| EPS Basic Continuous Ops | -0.35 | -1.10 | -2.31 | -0.81 | -1.07 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.04 | N/A | N/A |
| EPS Diluted Total Ops | -0.36 | -1.13 | -2.27 | -0.81 | -1.07 |
| EPS Diluted Continuous Ops | -0.35 | -1.10 | -2.31 | -0.81 | -1.07 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.04 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.36 | -1.13 | N/A | -0.57 | N/A |
| EBITDA(a) | $-4,306 | $-8,932 | $-15,854 | $-6,087 | $-7,837 |